Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

Salpeter SR, Greyber E, Pasternak GA, Salpeter EE.

Arch Intern Med. 2003 Nov 24;163(21):2594-602. Review.

PMID:
14638559
2.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter S, Greyber E, Pasternak G, Salpeter E.

Cochrane Database Syst Rev. 2003;(2):CD002967. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD002967.

PMID:
12804446
3.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter S, Greyber E, Pasternak G, Salpeter E.

Cochrane Database Syst Rev. 2002;(2):CD002967. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD002967.

PMID:
12076461
4.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter S, Greyber E, Pasternak G, Salpeter E.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002967. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD002967.

PMID:
16437448
5.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter SR, Greyber E, Pasternak GA, Salpeter EE.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002967. doi: 10.1002/14651858.CD002967.pub4. Review.

PMID:
20393934
6.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD002967. doi: 10.1002/14651858.CD002967.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD002967.

PMID:
20091535
7.

[Traditional contraindications to the use of metformin -- more harmful than beneficial?].

Holstein A, Egberts EH.

Dtsch Med Wochenschr. 2006 Jan 20;131(3):105-10. Review. German.

PMID:
16418951
8.

Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.

Kamber N, Davis WA, Bruce DG, Davis TM.

Med J Aust. 2008 Apr 21;188(8):446-9.

PMID:
18429709
9.

Incidence of lactic acidosis in metformin users.

Stang M, Wysowski DK, Butler-Jones D.

Diabetes Care. 1999 Jun;22(6):925-7.

10.

Lactic acidosis. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus.

DePalo VA, Mailer K, Yoburn D, Crausman RS.

Geriatrics. 2005 Nov;60(11):36, 39-41.

PMID:
16287340
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
12.

Contraindications can damage your health--is metformin a case in point?

Holstein A, Stumvoll M.

Diabetologia. 2005 Dec;48(12):2454-9. Epub 2005 Nov 11.

PMID:
16283245
13.

Metformin use in renal dysfunction: is a serum creatinine threshold appropriate?

Philbrick AM, Ernst ME, McDanel DL, Ross MB, Moores KG.

Am J Health Syst Pharm. 2009 Nov 15;66(22):2017-23. doi: 10.2146/ajhp080330.

PMID:
19890084
14.

Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.

van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ.

J Clin Pharm Ther. 2011 Jun;36(3):376-82. doi: 10.1111/j.1365-2710.2010.01192.x. Epub 2010 Aug 25.

PMID:
21545617
15.

Lactic acidosis rates in type 2 diabetes.

Brown JB, Pedula K, Barzilay J, Herson MK, Latare P.

Diabetes Care. 1998 Oct;21(10):1659-63. Erratum in: Diabetes Care 1998 Dec;21(12):2203.

PMID:
9773726
16.

Balancing risk and benefit with oral hypoglycemic drugs.

Hamnvik OP, McMahon GT.

Mt Sinai J Med. 2009 Jun;76(3):234-43. doi: 10.1002/msj.20116.

PMID:
19421967
17.

Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study.

Cryer DR, Nicholas SP, Henry DH, Mills DJ, Stadel BV.

Diabetes Care. 2005 Mar;28(3):539-43.

PMID:
15735184
18.

[Lactic acidosis and metformin implicated: why better information about risk factors?].

Machet G, Coudray JM.

Therapie. 2000 Mar-Apr;55(2):283-94. French.

PMID:
10967701
19.

Review of management of type 2 diabetes mellitus.

Yap WS, Peterson GM, Vial JH, Randall CT, Greenaway TM.

J Clin Pharm Ther. 1998 Dec;23(6):457-65.

PMID:
10048507
20.

[Value of biguanide in therapy of diabetes mellitus].

Haupt E, Panten U.

Med Klin (Munich). 1997 Aug 15;92(8):472-9, 505. Review. German.

PMID:
9340472

Supplemental Content

Support Center